The stock of Revolution Medicines Inc (RVMD) has seen a -7.27% decrease in the past week, with a -1.13% drop in the past month, and a 9.58% flourish in the past quarter. The volatility ratio for the week is 5.72%, and the volatility levels for the past 30 days are at 4.83% for RVMD. The simple moving average for the past 20 days is -7.44% for RVMD’s stock, with a 29.60% simple moving average for the past 200 days.
Is It Worth Investing in Revolution Medicines Inc (NASDAQ: RVMD) Right Now?
The stock has a 36-month beta value of 1.44. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for RVMD is 137.60M, and at present, short sellers hold a 11.46% of that float. On August 09, 2024, the average trading volume of RVMD was 1.53M shares.
RVMD) stock’s latest price update
The stock of Revolution Medicines Inc (NASDAQ: RVMD) has decreased by -0.69 when compared to last closing price of 42.27. Despite this, the company has experienced a -7.27% fall in its stock price over the last five trading sessions. globenewswire.com reported 2024-08-07 that REDWOOD CITY, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced its financial results for the quarter ended June 30, 2024, and provided an update on corporate progress.
Analysts’ Opinion of RVMD
Many brokerage firms have already submitted their reports for RVMD stocks, with Needham repeating the rating for RVMD by listing it as a “Buy.” The predicted price for RVMD in the upcoming period, according to Needham is $62 based on the research report published on July 16, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see RVMD reach a price target of $52. The rating they have provided for RVMD stocks is “Overweight” according to the report published on July 12th, 2024.
Jefferies gave a rating of “Buy” to RVMD, setting the target price at $63 in the report published on July 08th of the current year.
RVMD Trading at 1.02% from the 50-Day Moving Average
After a stumble in the market that brought RVMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.64% of loss for the given period.
Volatility was left at 4.83%, however, over the last 30 days, the volatility rate increased by 5.72%, as shares sank -3.16% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.77% upper at present.
During the last 5 trading sessions, RVMD fell by -7.27%, which changed the moving average for the period of 200-days by +50.09% in comparison to the 20-day moving average, which settled at $45.29. In addition, Revolution Medicines Inc saw 46.37% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RVMD starting from MARK A GOLDSMITH, who proposed sale 10,000 shares at the price of $45.64 back on Aug 01 ’24. After this action, MARK A GOLDSMITH now owns shares of Revolution Medicines Inc, valued at $456,400 using the latest closing price.
GOLDSMITH MARK A, the of Revolution Medicines Inc, sale 10,000 shares at $45.88 during a trade that took place back on Aug 01 ’24, which means that GOLDSMITH MARK A is holding 311,885 shares at $458,827 based on the most recent closing price.
Stock Fundamentals for RVMD
Current profitability levels for the company are sitting at:
- -809.61 for the present operating margin
- -9.47 for the gross margin
The net margin for Revolution Medicines Inc stands at -699.74. The total capital return value is set at -0.35. Equity return is now at value -40.73, with -36.03 for asset returns.
Based on Revolution Medicines Inc (RVMD), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -4.37. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is -64.67.
Currently, EBITDA for the company is -477.88 million with net debt to EBITDA at 0.31. When we switch over and look at the enterprise to sales, we see a ratio of 9080.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 15.42.
Conclusion
To sum up, Revolution Medicines Inc (RVMD) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
